Break Boundaries.
Ignite Change.

Pioneering the first dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer

First-in-Class Modulation of the Tumor Microenvironment

The dual mechanism of our T-win® technology is designed to activate and expand T cells to modulate the tumor microenvironment to fight cancer

Considering participation in a clinical trial?